Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomas
- 1 July 2004
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 17 (7) , 756-764
- https://doi.org/10.1038/modpathol.3800114
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Analysis of γc-Family Cytokine Target GenesJournal of Biological Chemistry, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Physical and Functional Interaction between GATA-3 and Smad3 Allows TGF-β Regulation of GATA Target GenesCurrent Biology, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Allelic loss in chromosomal region 1q21–23 in breast cancer is associated with peritumoral angiolymphatic invasion and extensive intraductal componentEuropean Journal of Surgical Oncology, 2000
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapyBreast Cancer Research and Treatment, 1992
- The Nottingham prognostic index in primary breast cancerBreast Cancer Research and Treatment, 1992
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991